ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2026)

ENDRA Life Sciences has disclosed Return on Assets across 10 years of filings, most recently posting 0.02% for Q1 2026.

• In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Assets climbed to 0.02% in Q1 2026, from 0.02% in the prior quarter.
• Over the last five years, Return on Assets for NDRA reached as high as 0.01% in Q2 2022 and fell as low as 0.03% in Q3 2025.
• The 5-year median for Return on Assets is 0.02% (2023), against an average of 0.02%.
• Annual changes were most pronounced in 2025 — Return on Assets declined 2 bps — and 2026, when it rose 1 bps.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then dropped by 15 bps to 0.01% in 2023, then slipped by 28 bps to 0.02% in 2024, then slumped by 35 bps to 0.02% in 2025, then grew by 17 bps to 0.02% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.02%, and 0.03% for Q1 2026, Q4 2025, and Q3 2025 respectively.